Clinical Trial Update: Multi-strain Probiotics to Prevent Necrotizing Enterocolitis in Very Preterm Infants [Phase 3]

View source ↗

Summary

Phase 3 trial to evaluate whether multi-strain probiotics can prevent necrotizing enterocolitis in very preterm infants; recruitment has not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Enterocolitis

Drugs mentioned

• Multi-strain Probiotics

Snippet

Sponsor: University of Calgary | Conditions: Necrotizing Enterocolitis (NEC) | Phase 3 | Status: NOT_YET_RECRUITING